Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

by palligoelme@gmail.com | Apr 14, 2026 | Clinical Trials

​ Conditions: Triple Negative Breast Cancer (TNBC) Sponsors: Peter MacCallum Cancer Centre, Australia; Hunter Medical Research Institute (HMRI); Royal Melbourne Hospital, Australia; Monash Health; Eastern Health; Mater Hospital Sydney; Chris O’Brien Lifehouse;...

Exercise, Pain Beliefs, and Activity Patterns in Musculoskeletal Pain

by palligoelme@gmail.com | Apr 14, 2026 | Clinical Trials

​ Conditions: Musculoskeletal Pain – Acute and Subacute Conditions; Exercise (EX); Beliefs; Activity Level Interventions: Other: This is an observational study. No interventions or treatments are administered. Sponsors: Istinye University Not yet...

Clinical Application of 89Zr-s-C1 PET/CT Imaging in Solid Tumors

by palligoelme@gmail.com | Apr 14, 2026 | Clinical Trials

​ Conditions: Solid Tumors Sponsors: Peking University Cancer Hospital & Institute Recruiting Conditions: Solid Tumors Sponsors: Peking University Cancer Hospital & Institute Recruiting 

Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)

by palligoelme@gmail.com | Apr 13, 2026 | Clinical Trials

​ Conditions: Recurrent Adenoid Cystic Carcinoma; Adenoid Cystic Carcinoma Metastatic; Papillary Thyroid Carcinoma Interventions: Drug: Sacituzumab Tirumotecan Sponsors: National Cancer Centre, Singapore; Merck Sharp & Dohme LLC; National Cancer Center, Japan Not...

A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants

by palligoelme@gmail.com | Apr 13, 2026 | Clinical Trials

​ Conditions: HIV Infections Interventions: Drug: VH4770359; Drug: Placebo; Drug: Midazolam Sponsors: ViiV Healthcare Not yet recruiting Conditions: HIV Infections Interventions: Drug: VH4770359; Drug: Placebo; Drug: Midazolam Sponsors: ViiV Healthcare Not yet...